Hi-Tech Pharmacal Return on Equity:
12.69% for Jan. 31, 2013Hi-Tech Pharmacal Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Jan. 31, 2013 | 12.69% |
| Oct. 31, 2012 | 15.15% |
| July 31, 2012 | 18.17% |
| April 30, 2012 | 22.98% |
| Jan. 31, 2012 | 25.96% |
| Oct. 31, 2011 | 27.65% |
| July 31, 2011 | 27.60% |
| April 30, 2011 | 26.51% |
| Jan. 31, 2011 | 24.26% |
| Oct. 31, 2010 | 24.99% |
| July 31, 2010 | 25.29% |
| April 30, 2010 | 27.91% |
| Jan. 31, 2010 | 29.56% |
| Oct. 31, 2009 | 25.57% |
| July 31, 2009 | 20.30% |
| April 30, 2009 | 12.34% |
| Jan. 31, 2009 | 6.45% |
| Oct. 31, 2008 | 1.76% |
| July 31, 2008 | -0.93% |
| April 30, 2008 | Go Pro |
| Jan. 31, 2008 | Go Pro |
| Oct. 31, 2007 | Go Pro |
| July 31, 2007 | Go Pro |
| April 30, 2007 | Go Pro |
| Jan. 31, 2007 | Go Pro |
| Oct. 31, 2006 | Go Pro |
| July 31, 2006 | Go Pro |
| April 30, 2006 | Go Pro |
| Jan. 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
HITK Return on Equity Benchmarks
| Companies | |
|---|---|
| Columbia Laboratories | 36.78% |
| SciClone Pharmaceuticals | 6.28% |
| Sagent Pharmaceuticals | 0.97% |
HITK Return on Equity Rankings
| Overall |
82nd percentile 1416 of 8002 |
| Sector |
80th percentile 125 of 650 in Healthcare |
| Industry |
81st percentile 12 of 65 in Drug Manufacturers - Specialty & Generic |
HITK Return on Equity Range, Past 5 Years
| Minimum | -0.93% | Jul 2008 |
| Maximum | 29.56% | Jan 2010 |
| Average | 19.69% |
